Prophylactic Properties of Carrot Juice in Patients With High-Risk Colorectal Polyps
Polyp Prophylactic Properties of Polyacetylenes in Patients With Previous Polypectomy
Odense University Hospital
400 participants
Jun 20, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this prospective randomized double-blinded bi-national study is to test the prophylactic effect of polyacetylenes from carrots on the population of patients who had a resection of high-risk adenomas of the large bowel. The main question it aims to answer is: Will carrot juice rich in polyacetylenes inhibit neoplastic transformation and growth in high-risk humans? Participants will have to drink 100 ml of juice daily after the adenoma resection for 1 year and keep a simple diary/calendar. Researchers will compare the group with ingestion of Falcarinol (FaOH) / Falcarindiol (FaDOH) rich carrot juice versus the group consuming placebo juice, to see if the polyacetylenes significantly reduces neoplastic transformation and growth in high-risk patients.
Eligibility
Inclusion Criteria3
- Any type of resection for adenomas larger than 20 mm in size (endoscopically evaluated) or endoscopically resected T1 cancers.
- Acceptance of the treatment and follow-up program.
- Capability to understand and follow the instructions.
Exclusion Criteria7
- Patients allocated to "high-risk" group because of many small polyps (\>4).
- Pregnancy.
- Known relevant allergies.
- Chronic consumption of COX (cyclooxygenase) inhibitors (Aspirin, Celecoxib, Ibuprofen, Diclofenac, Ketoprofen, Ketorolac, Indometacin, Naproxen, Piroxicam) or immunosuppressive agents (Methotrexate, Azathioprine or glucocorticoids).
- Patients with different neoplastic disease under treatment (Chemo-/Radio-/Imunotherapy).
- Severe comorbidity NYHA III-IV.
- Lynch syndrome.
Interventions
Consumption of 100 ml of carrot juice daily for 1 year
Consumption of 100 ml of placebo juice daily for 1 year
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06335420